Indication
t(11;14)
1 clinical trial
3 products
Clinical trial
Phase I Clinical Trial of Venetoclax (ABT-199) in Combination With Ixazomib and Dexamethasone for Patients With Relapsed Multiple MyelomaStatus: Completed, Estimated PCD: 2021-12-20
Product
DexamethasoneProduct
IxazomibProduct
Venetoclax